Guinea-Bissau vs Syrian Arab Republic: Hepatitis B surface antigen (HBsAg) prevalence
Guinea-Bissau
2.7%
in 2024
Syrian Arab Republic
2.9%
in 2024
Guinea-Bissau rank
8th
Syrian Arab Republic rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Guinea-Bissau
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 2.7% in Guinea-Bissau, a difference of 0.2%.
That makes Syrian Arab Republic's figure about 1.1 times Guinea-Bissau's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 8th and Syrian Arab Republic ranks 6th of 194 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.8% | 3.5% | 0.7% | Syrian Arab Republic |
| 2020s | 2.7% | 3.4% | 0.7% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Guinea-Bissau or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 2.7% in Guinea-Bissau as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Guinea-Bissau and Syrian Arab Republic?
- 0.2%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Guinea-Bissau and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea-Bissau and Syrian Arab Republic rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Guinea-Bissau ranks 8th and Syrian Arab Republic ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.